| 2025 | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 75,3 k € | +31.1% | 57,4 k € | -41.9% | 98,8 k € | -60.3% | 249,1 k € | +123.3% | 111,6 k € | +1.9% | 109,5 k € | +4.3% | 105,0 k € | -3.5% | 108,9 k € | +16.4% | 93,6 k € | -16.7% | 112,3 k € | -18.6% | 137,9 k € | -13.3% | 159,1 k € | +35.6% | 117,3 k € | -28.8% | 164,6 k € | +3.7% | 158,7 k € | +19.8% | 132,5 k € | +5.4% | 125,7 k € | |
| EBITDA | 74,1 k € | +31.1% | 56,5 k € | -39.5% | 93,5 k € | -62.1% | 246,5 k € | +129.6% | 107,4 k € | +6.0% | 101,3 k € | +1.8% | 99,6 k € | -3.5% | 103,1 k € | +18.8% | 86,8 k € | -18.9% | 107,0 k € | -17.0% | 128,8 k € | -17.2% | 155,5 k € | +36.5% | 113,9 k € | -29.3% | 161,1 k € | +3.0% | 156,4 k € | +20.5% | 129,8 k € | +5.4% | 123,1 k € | |
| Operating profit | 74,1 k € | +31.8% | 56,2 k € | -38.4% | 91,3 k € | -59.0% | 222,4 k € | +164.6% | 84,0 k € | +5.9% | 79,4 k € | -0.6% | 79,9 k € | -2.9% | 82,2 k € | +34.0% | 61,4 k € | -23.8% | 80,6 k € | -22.1% | 103,4 k € | -19.0% | 127,7 k € | +33.8% | 95,5 k € | -34.3% | 145,3 k € | +16.5% | 124,7 k € | +47.4% | 84,6 k € | +32.9% | 63,7 k € | |
| Profit/loss | 59,0 k € | +6.9% | 55,2 k € | -22.5% | 71,2 k € | -52.3% | 149,2 k € | +174.0% | 54,5 k € | -0.8% | 54,9 k € | -2.7% | 56,5 k € | +3.9% | 54,3 k € | +25.0% | 43,5 k € | -18.7% | 53,4 k € | -21.3% | 67,9 k € | -18.1% | 82,9 k € | +24.3% | 66,7 k € | -37.4% | 106,6 k € | +18.3% | 90,1 k € | +48.3% | 60,7 k € | +25.6% | 48,4 k € | |
| Equity | 431,6 k € | -1.1% | 436,5 k € | 0.0% | 436,5 k € | -19.6% | 542,9 k € | +190.2% | 187,1 k € | -15.9% | 222,4 k € | +32.8% | 167,5 k € | +50.8% | 111,1 k € | -29.1% | 156,7 k € | +38.4% | 113,3 k € | -39.0% | 185,8 k € | +57.6% | 117,9 k € | +236.7% | 35,0 k € | -79.2% | 168,3 k € | +106.1% | 81,7 k € | -26.8% | 111,6 k € | +57.5% | 70,8 k € | |
| Total assets | 452,6 k € | -12.2% | 515,3 k € | -2.0% | 526,0 k € | -8.3% | 573,8 k € | +177.8% | 206,5 k € | -21.8% | 264,1 k € | +9.4% | 241,5 k € | +2.2% | 236,2 k € | +30.2% | 181,4 k € | -30.3% | 260,2 k € | +14.4% | 227,5 k € | +28.1% | 177,6 k € | -42.7% | 310,0 k € | +28.5% | 241,2 k € | -16.8% | 290,0 k € | +22.7% | 236,5 k € | +6.2% | 222,6 k € | |
| Cash | 31,2 k € | -82.2% | 175,0 k € | +819.0% | 19,0 k € | -96.2% | 495,1 k € | +288.9% | 127,3 k € | +626.3% | 17,5 k € | -65.6% | 50,9 k € | +31.5% | 38,7 k € | +47.1% | 26,3 k € | +82.9% | 14,4 k € | -33.6% | 21,7 k € | -23.5% | 28,3 k € | -53.7% | 61,1 k € | +503.0% | 10,1 k € | -54.7% | 22,4 k € | +168.1% | 8,3 k € | +13.5% | 7,4 k € | |
| Debts | 17,3 k € | -74.8% | 68,6 k € | -9.9% | 76,1 k € | +818.2% | 8,3 k € | +143.2% | 3,4 k € | -87.6% | 27,4 k € | -53.9% | 59,4 k € | -52.3% | 124,6 k € | +416.1% | 24,1 k € | -83.5% | 146,3 k € | +256.4% | 41,1 k € | -30.5% | 59,1 k € | -78.4% | 274,2 k € | +279.0% | 72,3 k € | -65.0% | 206,5 k € | +65.3% | 124,9 k € | -17.7% | 151,8 k € | |
| Staff | — | — | — | — | — | — | — | 0,1 | 0,3 | 1 | 0,6 | 0,1 | 0,9 | 0,9 | 0,9 | 0,9 | 0,5 | |||||||||||||||||
Private company with limited liability · Ans · incorporated on 16/03/2001
Private company with limited liability profitable and well capitalised. Cash position declining (-82.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOCTEURS GIELEN & COUNE is a Private company with limited liability incorporated in 2001. Its main activity is: General medical practice activities. Its registered office is in Ans.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette